Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements
NCT ID: NCT04668664
Last Updated: 2022-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2021-04-05
2022-06-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing a Direct Versus an Indirect Approach to Measuring the Portalsytemic Pressure Gradients
NCT04987034
EUS Guided Portal-systemic Pressure Gradient Measurement
NCT04633356
Endoscopic Ultrasound-guided Measurement of Portal Vein Pressure Gradient
NCT07062289
EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.
NCT04191369
EUS-PPG vs HVPG in Portal Hypertension
NCT05689268
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EchoTip® Insight™ Portosystemic Pressure Gradient Measurement System (EchoTip® Insight™)
Measuring the portal pressure gradient in patients with cirrhosis who are referred for an esophagogastroduodenoscopy (EGD) and/or endoscopic ultrasound (EUS).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patient is unwilling or unable to sign and date the informed consent.
* Patient is unwilling or unable to comply with the follow-up study schedule.
* Patient for whom endoscopic procedures are contraindicated
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cook Research Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth Chang, MD, FACG, FASGE
Role: PRINCIPAL_INVESTIGATOR
University of California, Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Irvine
Orange, California, United States
The University of Kansas Health System
Kansas City, Kansas, United States
Brigham & Women's Hospital
Boston, Massachusetts, United States
New York-Presbyterian Hospital/Weill Cornell University Medical Center
New York, New York, United States
University of Virginia Medical Center
Charlottesville, Virginia, United States
Royal Brisbane Women's Hospital
Herston, , Australia
Prince of Wales Hospital/Chinese University of Hong Kong
Shatin, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.